Zeit | Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
16.06.24 | AstraZeneca's Calquence Combo Cuts Progression Risk By 27% In Mantle Cell Lymphoma Trial | 739 | AFX News | LONDON (dpa-AFX) - AstraZeneca Plc. (AZN.L) said that results from the ECHO Phase III trial showed the company's Calquence (acalabrutinib) in combination with bendamustine and rituximab demonstrated... ► Artikel lesen | |
16.06.24 | Roche: Phase III Study Of Columvi Combo Extends Survival In Relapsed Diffuse Large B-Cell Lymphoma | 861 | AFX News | SOUTH SAN FRANCISCO (dpa-AFX) - Roche (RHHBY) announced statistically significant and clinically meaningful results from its Phase III STARGLO study of Columvi (glofitamab) in combination with... ► Artikel lesen |
Suchbegriffe der letzen 24 h | Anzahl |
---|---|
NVIDIA | 2.037 |
NOVO NORDISK | 1.969 |
PUMA | 1.776 |
BAYER | 1.494 |
D-WAVE QUANTUM | 1.493 |
TUI | 1.471 |
EVOTEC | 1.465 |
DEUTSCHE BANK | 1.082 |
BASF | 1.019 |
RHEINMETALL | 948 |
VARTA | 916 |
NEL | 893 |
TESLA | 883 |
RENK GROUP | 854 |
PLUG POWER | 835 |
COMMERZBANK | 782 |
THYSSENKRUPP | 721 |
SIEMENS ENERGY | 690 |
BIONTECH | 664 |
MEDIGENE | 664 |
VOLKSWAGEN | 635 |
HEIDELBERGER DRUCK | 627 |
DEUTSCHE TELEKOM | 626 |
DEUTSCHE LUFTHANSA | 623 |
BYD | 613 |